Cresco advised the general partner of the Novalis funds in the structuring, formation and fundraising of Novalis and Novalis II.
Novalis Biotech seeds biotechnology and life sciences related companies.
Its core competence lies in the interaction between bioinformatics, genomics and digitalization in life sciences.
David Dessers and Anouck Van Elsen constituted the deal team for these fund formations and will continue to support the Novalis funds in their investment and divestment activities.
For any further information or questions, please contact David Dessers.
More information can be found in De Tijd.